Landscape of genetic lesions in 944 patients with myelodysplastic syndromes T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, ... Leukemia 28 (2), 241-247, 2014 | 1661 | 2014 |
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade DS Thommen, VH Koelzer, P Herzig, A Roller, M Trefny, S Dimeloe, ... Nature medicine 24 (7), 994-1004, 2018 | 886 | 2018 |
Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors DS Thommen, J Schreiner, P Müller, P Herzig, A Roller, A Belousov, ... Cancer immunology research 3 (12), 1344-1355, 2015 | 368 | 2015 |
MicroRNA loss enhances learning and memory in mice W Konopka, A Kiryk, M Novak, M Herwerth, JR Parkitna, M Wawrzyniak, ... Journal of Neuroscience 30 (44), 14835-14842, 2010 | 366 | 2010 |
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML) M Meggendorfer, A Roller, T Haferlach, C Eder, F Dicker, V Grossmann, ... Blood, The Journal of the American Society of Hematology 120 (15), 3080-3088, 2012 | 335 | 2012 |
A novel hierarchical prognostic model of AML solely based on molecular mutations V Grossmann, S Schnittger, A Kohlmann, C Eder, A Roller, F Dicker, ... Blood, The Journal of the American Society of Hematology 120 (15), 2963-2972, 2012 | 317 | 2012 |
Landscape of TET2 mutations in acute myeloid leukemia S Weissmann, T Alpermann, V Grossmann, A Kowarsch, N Nadarajah, ... Leukemia 26 (5), 934-942, 2012 | 307 | 2012 |
PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes A Ruepp, A Kowarsch, D Schmidl, F Buggenthin, B Brauner, I Dunger, ... Genome biology 11, 1-11, 2010 | 300 | 2010 |
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients S Jeromin, S Weissmann, C Haferlach, F Dicker, K Bayer, V Grossmann, ... Leukemia 28 (1), 108-117, 2014 | 298 | 2014 |
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy M Mayoux, A Roller, V Pulko, S Sammicheli, S Chen, E Sum, C Jost, ... Science translational medicine 12 (534), eaav7431, 2020 | 289 | 2020 |
The molecular profile of adult T‐cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T‐ALL V Grossmann, C Haferlach, S Weissmann, A Roller, S Schindela, ... Genes, Chromosomes and Cancer 52 (4), 410-422, 2013 | 188 | 2013 |
Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain S Soverini, C De Benedittis, K Machova Polakova, A Brouckova, D Horner, ... Blood, The Journal of the American Society of Hematology 122 (9), 1634-1648, 2013 | 183 | 2013 |
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease A Kohlmann, N Nadarajah, T Alpermann, V Grossmann, S Schindela, ... Leukemia 28 (1), 129-137, 2014 | 126 | 2014 |
Landmark analysis of DNMT3A mutations in hematological malignancies A Roller, V Grossmann, U Bacher, F Poetzinger, S Weissmann, ... Leukemia 27 (7), 1573-1578, 2013 | 104 | 2013 |
Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation TC Jungraithmayr, K Hofer, P Cochat, G Chernin, G Cortina, S Fargue, ... Journal of the American Society of Nephrology 22 (3), 579-585, 2011 | 98 | 2011 |
Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier B Balluff, M Elsner, A Kowarsch, S Rauser, S Meding, C Schuhmacher, ... Journal of proteome research 9 (12), 6317-6322, 2010 | 88 | 2010 |
Hypothalamic miR-103 protects from hyperphagic obesity in mice IA Vinnikov, K Hajdukiewicz, J Reymann, J Beneke, R Czajkowski, ... Journal of Neuroscience 34 (32), 10659-10674, 2014 | 87 | 2014 |
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients S Weissmann, A Roller, S Jeromin, M Hernandez, M Abaigar, ... Leukemia 27 (12), 2393-2396, 2013 | 87 | 2013 |
Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets V Raia, M Schilling, M Böhm, B Hahn, A Kowarsch, A Raue, C Sticht, ... Cancer research 71 (3), 693-704, 2011 | 86 | 2011 |
Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity U Bacher, S Schnittger, K Macijewski, V Grossmann, A Kohlmann, ... Blood, The Journal of the American Society of Hematology 119 (20), 4719-4722, 2012 | 80 | 2012 |